I don't think the team he has built is unreasonable. Developing a health / medical product is not a simple thing. Mr. James has been smart with money and strategy so far. There are always significant research costs in a start up. As long as they remain focused and execute, it will be great for all.
He understands cash flow and that is key for a start up environment. Otherwise once you are out you are done. Unethical types will screw the shareholders sometimes while the ship is going down, but I really don't think this is the case here one bit.
I personally like the 'completed the group' so we know a) we have everyone needed to commercialize a product (ie Mr James has a product development plan and has resourced it appropriately) and b) we can expect things to move along now ie execute
Therefore no red flags at all. Just moving along. Just my $.02
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.